Title |
Exosomes are natural carriers of exogenous siRNA to human cells in vitro
|
---|---|
Published in |
Cell Communication and Signaling, November 2013
|
DOI | 10.1186/1478-811x-11-88 |
Pubmed ID | |
Authors |
Tatyana A Shtam, Roman A Kovalev, Elena Yu Varfolomeeva, Evgeny M Makarov, Yury V Kil, Michael V Filatov |
Abstract |
Exosomes are nano-sized vesicles of endocytic origin that are involved in cell-to-cell communication including shuttle RNA, mainly mRNA and microRNA. As exosomes naturally carry RNA between cells, these particles might be useful in gene cancer therapy to deliver therapeutic short interfering RNA (siRNA) to the target cells. Despite the promise of RNA interference (RNAi) for use in therapy, several technical obstacles must be overcome. Exogenous siRNA is prone to degradation, has a limited ability to cross cell membranes and may induce an immune response. Naturally occurring RNA carriers, such as exosomes, might provide an untapped source of effective delivery strategies. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Chile | 2 | <1% |
United States | 2 | <1% |
Turkey | 1 | <1% |
Brazil | 1 | <1% |
Canada | 1 | <1% |
Czechia | 1 | <1% |
Denmark | 1 | <1% |
Belgium | 1 | <1% |
Unknown | 380 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 85 | 22% |
Researcher | 59 | 15% |
Student > Bachelor | 49 | 13% |
Student > Master | 43 | 11% |
Student > Doctoral Student | 21 | 5% |
Other | 38 | 10% |
Unknown | 95 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 92 | 24% |
Agricultural and Biological Sciences | 75 | 19% |
Medicine and Dentistry | 29 | 7% |
Engineering | 22 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 17 | 4% |
Other | 40 | 10% |
Unknown | 115 | 29% |